Utrecht

• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/ … Not authorised
  2022-500410-26-00 5 Cystic Fibrosis
• Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Not authorised
  2022-502968-20-01 4 Idiopathic Inflammatory Myopathies
• Baricitinib for treating hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international phase II … Not authorised
  2023-503480-42-00 10 Hospital-acquired pneumonia
• RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Not authorised
  2024-511580-28-00 5 PASC: post-acute sequelae of SARS-CoV-2 infection
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Not authorised
  2024-514693-47-00 11 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• A study to assess the long-term safety and clinical activity of mRNA-3927 in participants previously enrolled in the mRNA-3927-P101 study Pending
  2022-502911-12-00 9 Propionic Acidemia
• The PACMAN-Hu19 trial: a phase I/II study with locally produced CD19-targeted CAR T-cell therapy Pending
  2023-507597-40-00 9 B-cell precursor ALL
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults Pending
  2024-511510-20-00 4 craniopharyngioma
• A randomized, placebo-controlled, double blind trial to study the effects of Etidronate on ectopic CALCIfication in FAhr’s Disease or syndro … Pending
  2024-512300-19-00 4 Fahr's disease
• Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco … Pending
  2024-512850-10-00 5 Resectable colorectal rectal metastases without extrahepatic disease
• mFBG PET-CT scan for the imaging of pheochromocytoma Pending
  2024-513622-35-00 4 Pheochromocytoma – endocrine adrenal tumor
• Extension Study of ACT-EARLY Pending
  2024-513676-18-00 5 Transthyretin Amyloidosis
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 10 Medulloblastoma
• Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery Pending
  2024-514089-37-00 4 Patients with pulmonary metastasis from any primary tumour, or who hav
• Clinical study to check the Efficacy and Safety of Mitapivat in Patients with Sickle Cell Disease Pending
  2024-515202-84-00 10 Anemia in subjects with sickle cell disease (SCD)
• BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending
  2024-516115-24-00 9 High risk relapsed neuroblastoma (relapsed or progressed after being d
• A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP … Pending
  2024-516570-30-00 4 Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
• Head-to-head comparison of six different botox products voor glabellar frown wrinkles. Pending
  2024-516865-35-01 6 Glabellar frown rhytides (wrinkles).
• Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending
  2024-517133-40-00 5 newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC ampli
• ATLAS trial Pending
  2024-517233-40-00 6 Perianal abscess
• Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer. Pending
  2024-518570-13-00 10 Resectable peritoneal metastases of a colorectal origin
• ESTIS trial: Early Stop of targeted Treatment in children with Systemic JIA. Pending
  2024-518684-35-00 6 autoimmune disorders, joint disorders synonym: Still's disease, system
• FIDES: Focused Ultrasound-mediated Blood-Brain Barrier Opening In Pontine Diffuse Midline Glioma (DMG) to Enhance Systemic Therapy with Temo … Pending
  2025-520814-78-00 9 Diffuse Midline Glioma, H3K27-altered

Showing 1–24 of 628 trials